查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球經皮給藥系統市場 2023-2030
市場調查報告書
商品編碼
1351034

全球經皮給藥系統市場 2023-2030

Global Transdermal Drug Delivery Systems Market 2023-2030
出版日期: | 出版商: Orion Market Research | 英文 130 Pages | 商品交期: 2-3個工作天內

價格

預計在預測期內（2023-2030年），全球經皮給藥系統市場將以 6.5% 的年複合成長率成長。經皮給藥系統（TDDS）屬於受控給藥系統，藥物以固定且受控的速率通過皮膚輸送。這些系統用於治療各種疾病，例如心血管疾病和中樞神經系統疾病等。最近在 2023 年 4 月，FDA 更新了文件，以澄清申辦者在測量 TDS 產品表面積時應考慮的適當方法。預期粘附在患者皮膚上以及如何統計分析該數據。這就是 FDA 更新通用經皮和局部給藥系統指南的原因。它針對使用經皮和局部給藥系統（TDS）的學名藥提交發布了兩份修訂指南草案。修訂後的指南對簡化新藥申請 (ANDA) 申辦者在提交上市前申請時應考慮的大量技術進行了澄清。

細分市場前景

全球經皮給藥系統市場按類型和應用進行細分。根據類型，市場分為貼片和凝膠。根據應用，市場細分為高血壓、暈動病、疼痛管理等。在該類型中，預計貼片細分市場將佔據相當大的市場佔有率。由於其用於疼痛管理，這正在促進市場成長。而癌症病例的不斷增加，導致疼痛補丁的加速出現。

預計疼痛管理細分市場將在全球經皮給藥系統市場中佔據相當大的佔有率

其中，疼痛管理細分市場預計將在全球經皮給藥系統市場中佔據相當大的佔有率。患者對無痛給藥的偏好不斷提高，導致用於給藥的黏性皮膚貼片的採用率大幅上升，預計這將為該市場帶來高成長潛力。因此，各公司都致力於進入並改善這一領域。例如，2023 年 6 月，Innocan Pharma Corporation 宣布向美國專利商標局 (USPTO) 提交最新專利申請。此舉符合該公司擴大其獨特的大麻和鎂局部止痛技術組合的持續策略。

區域展望

全球經皮給藥系統市場根據地理位置進一步細分，包括北美（美國和加拿大）、歐洲（英國、義大利、西班牙、德國、法國和歐洲其他地區）、亞太地區（印度、中國） 、日本、韓國和亞洲其他地區）以及世界其他地區（中東和非洲以及拉丁美洲）。其中，由於德國、英國和俄羅斯等國家擁有先進的醫療基礎設施，預計歐洲將在全球市場中佔有顯著佔有率。

北美地區預計全球經皮給藥系統市場年複合成長率顯著成長

在所有地區中，北美地區預計在預測期內將以相當大的年複合成長率成長。區域成長歸因於該地區目標疾病（如慢性疼痛、中樞神經系統疾病和心血管疾病）盛行率的上升，以及與經皮給藥系統相關的研究活動數量的增加。因此，該國正大力轉向採用經皮給藥系統市場解決方案。例如，2023 年 4 月，DifGen Pharmaceuticals LLC 宣布收購了 Aveva Drug Delivery Services Inc.，一家完全整合的經皮給藥系統 (TDS) 和口服可溶性薄膜 (ODF) 開發商和製造商。這項戰略投資使我們能夠擴大我們的研發和製造能力，提供複雜的劑型，並透過美國當地的製造為我們有價值的合作夥伴提供安全的供應。最重要的是，它將為患者提供負擔得起的、最高品質和持續供應的救生藥物」。

市場參與者展望

服務於經皮給藥系統市場的主要公司包括 Boehringer Ingelheim GmbH、Echo Therapeutics Inc.、GlaxoSmithKline plc、Hisamitsu Pharmaceutical Co. Inc.、Mylan Pharmaceuticals, Inc. 等。市場參與者透過各種策略（包括併購、合作、合作、融資和新產品發布），為市場成長做出了巨大貢獻，以保持市場競爭力。例如，2023年6月，Kyung Hee與Dasan Pharmaceutical簽署了一項新技術轉移協議，涉及一項開創性的經皮給藥材料技術，該技術採用了醫學院Dokyoung Kim教授開發的新型高分子化合物。

報告涵蓋：

  • 2022年市場價​​值數據分析及2030年預測。
  • 每個細分市場的年化市場收入（百萬美元）。
  • 主要地理區域的國家分析。
  • 全球經皮給藥系統市場的主要公司。根據現有數據，報告中還提供了與新產品發布相關的資訊以及相關新聞。
  • 透過確定未來強勁成長的關鍵細分市場來分析業務策略。
  • 市場進入和市場擴張策略分析。
  • 透過識別市場中「誰的立場」來制定競爭策略。

目錄

第 1 章：報告摘要

  • 目前行業分析及成長潛力展望
  • 研究方法和工具
  • 市場區隔
    • 按細分
    • 按地區

第 2 章：市場概述與見解

  • 報告範圍
  • 分析師見解和當前市場趨勢
    • 主要發現
    • 建議
    • 結論

第 3 章：競爭格局

  • 主要公司分析
  • 3M Company
    • 概述
    • 財務分析
    • SWOT分析
    • 最近的發展
  • Johnson & Johnson
    • 概述
    • 財務分析
    • SWOT分析
    • 最近的發展
  • Skyepharma Production SAS
    • 概述
    • 財務分析
    • SWOT分析
    • 最近的發展
  • 關鍵策略分析

第 4 章：市場細分

  • 按類型分類的全球經皮給藥系統市場
    • 補丁
    • 凝膠
  • 全球經皮給藥系統市場（依應用）
    • 高血壓
    • 暈動症
    • 疼痛管理
    • 其他（+感染、荷爾蒙、呼吸和代謝）

第 5 章：區域分析

  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 西班牙
    • 法國
    • 歐洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 世界其他地區

第 6 章：公司簡介

  • 4P Therapeutics, LLC
  • Altaris
  • Bayer AG
  • Biogel Technology, Inc.
  • Boehringer Ingelheim GmbH
  • Echo Therapeutics, Inc.
  • GlaxoSmithKline plc
  • Hisamitsu Pharmaceutical Co. Inc.
  • Mylan Pharmaceuticals, Inc.
  • Novartis AG
  • Noven Pharmaceuticals, Inc.
  • Purdue Pharma L.P.
  • Transdermal Technologies, Inc.
  • Viatris Inc.
  • Watson Pharmaceuticals, Inc.
Product Code: OMR2027635

Title: Global Transdermal Drug Delivery Systems Market Size, Share & Trends Analysis Report by Type (Patches and gel), by Application (Hypertension, Motion Sickness, Pain Management and Others),Forecast Period (2023-2030).

The global transdermal drug delivery systems market is anticipated to grow at a CAGR of 6.5% during the forecast period (2023-2030). Transdermal drug delivery system (TDDS) is the systems categorized under the controlled drug delivery, where drugs are delivered through the skin at a fixed and controlled rate. These systems are used for treating various disease conditions such as cardiovascular disorders, and central nervous system disorders, etc. Recently in April 2023, FDA updated the documents to clarify the appropriate methods sponsors should consider while measuring the surface area of the TDS product that is expected to adhere to a patient's skin and how to statistically analyze that data. That why FDA updates generic transdermal and topical delivery systems guidance's. It issued two revised draft guidance for generic drug submissions that use transdermal and topical delivery systems (TDS). The revised guidance make numerous technical clarifications that abbreviated new drug application (ANDA) sponsors should consider when filing their premarket application.

Segmental Outlook

The global transdermal drug delivery systems market is segmented on the type and application. Based on the type, the market is sub-segmented into patches and gel. Based on the application, the market is sub-segmented into hypertension, motion sickness, pain management and others. Among the type, the patches sub-segment is anticipated to hold a considerable share of the market. Owing to its use in pain management, which is boosting the market growth. And the increasing cases of cancer, lead accelerated embracing of pain patches.

The Pain Management Sub-Segment is Anticipated to Hold a Considerable Share of the Global Transdermal Drug Delivery Systems Market

Among the application, the Pain management sub-segment is expected to hold a considerable share of the global transdermal drug delivery system market. The rising patient preference for pain-free drug administration has led to a significant surge in the adoption rate of adhesive skin patches that administer drugs, which is anticipated to present the market with high growth potential. Hence Companies are focusing to enter and improve in this segment. For an instance, in June 2023, Innocan Pharma Corporation has announced the filing of its most recent patent application to the United States Patent and Trademark Office (USPTO). This move is in line with the Company's ongoing strategy to expand the breadth of its distinctive combined Cannabis and Magnesium topical pain-relief technology.

Regional Outlook

The global transdermal drug delivery systems market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, Europe is anticipated to hold a prominent share of the market across the globe, owing to presence of advanced healthcare infrastructure facilities in countries like Germany, UK and Russia.

The North America Region is Expected to Grow at a Significant CAGR in the Global Transdermal Drug Delivery Systems Market

Among all regions, the North America regions is anticipated to grow at a considerable CAGR over the forecast period. Regional growth is attributed to the region is driven by the rising prevalence of targeted diseases (such as chronic pain, central nervous system disorders, and cardiovascular diseases) in the region, and the increasing number of research activities related to transdermal drug delivery systems. Hence, there is considerable shift of the country towards the adoption of the Transdermal Drug Delivery Systems market solutions. For an instance in April 2023, DifGen Pharmaceuticals LLC announced that it has acquired Aveva Drug Delivery Services Inc. a fully integrated developer and manufacturer of Transdermal Delivery Systems (TDS) and Oral Dissolvable Films (ODF). This strategic investment allows us to expand our R&D & manufacturing capabilities in offering complex dosage forms and secure supply to our valuable partners with local US based manufacturing. Most importantly, it will provide patients affordable lifesaving medication with highest quality and consistent supply".

Market Players Outlook

The major companies serving the transdermal drug delivery systems market includes Boehringer Ingelheim GmbH, Echo Therapeutics Inc., GlaxoSmithKline plc, Hisamitsu Pharmaceutical Co. Inc., Mylan Pharmaceuticals, Inc., and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in June 2023, Kyung Hee signed a new technology transfer agreement with Dasan Pharmaceutical for a pioneering transdermal drug delivery material technology that incorporates a novel polymer compound developed by Professor Dokyoung Kim of the College of Medicine.

The Report Covers:

  • Market value data analysis of 2022 and forecast to 2030.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global transdermal drug delivery systems market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. 3M Company
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. Johnson & Johnson
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. Skyepharma Production SAS
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global Transdermal Drug Delivery Systems Market by Type
    • 4.1.1. Patches
    • 4.1.2. Gel
  • 4.2. Global Transdermal Drug Delivery Systems Market by Application
    • 4.2.1. Hypertension
    • 4.2.2. Motion Sickness
    • 4.2.3. Pain Management
    • 4.2.4. Others (+Infection, Hormone, Respiratory and Metabolic)

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. 4P Therapeutics, LLC
  • 6.2. Altaris
  • 6.3. Bayer AG
  • 6.4. Biogel Technology, Inc.
  • 6.5. Boehringer Ingelheim GmbH
  • 6.6. Echo Therapeutics, Inc.
  • 6.7. GlaxoSmithKline plc
  • 6.8. Hisamitsu Pharmaceutical Co. Inc.
  • 6.9. Mylan Pharmaceuticals, Inc.
  • 6.10. Novartis AG
  • 6.11. Noven Pharmaceuticals, Inc.
  • 6.12. Purdue Pharma L.P.
  • 6.13. Transdermal Technologies, Inc.
  • 6.14. Viatris Inc.
  • 6.15. Watson Pharmaceuticals, Inc.

LIST OF TABLES

  • 1. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 2. GLOBAL TRANSDERMAL PATCHES MARKET RESEARCH AND ANALYSIS BY REGION,2022-2030 ($ MILLION)
  • 3. GLOBAL TRANSDERMAL GEL MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 4. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 5. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEMS FOR HYPERTENSION MARKET RESEARCH AND ANALYSIS, 2022-2030 ($ MILLION)
  • 6. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEMS FOR MOTION SICKNESS MARKET RESEARCH AND ANALYSIS, 2022-2030 ($ MILLION)
  • 7. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEMS FOR PAIN MANAGEMENT MARKET RESEARCH AND ANALYSIS, 2022-2030 ($ MILLION)
  • 8. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEMS FOR OTHERS MARKET RESEARCH AND ANALYSIS, 2022-2030 ($ MILLION)
  • 9. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 10. NORTH AMERICAN TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 11. NORTH AMERICAN TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 12. NORTH AMERICAN TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 13. EUROPEAN TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 14. EUROPEAN TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 15. EUROPEAN TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 16. ASIA- PACIFIC TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 17. ASIA- PACIFIC TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 18. ASIA- PACIFIC TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)
  • 19. REST OF THE WORLD TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 20. REST OF THE WORLD TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 21. REST OF THE WORLD TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET SHARE BY TYPE, 2022 VS 2030 (%)
  • 2. GLOBAL TRANSDERMAL PATCHES MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 3. GLOBAL TRANSDERMAL GEL MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 4. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET SHARE BY APPLICATION, 2022 VS 2030 (%)
  • 5. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEMS FOR HYPERTENSION MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 6. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEMS FOR MOTION SICKNESS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 7. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEMS FOR PAIN MANAGEMENT MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 8. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEMS FOR OTHERS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 9. GLOBAL TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 10. US TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET SIZE, 2022-2030 ($ MILLION)
  • 11. CANADA TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET SIZE, 2022-2030 ($ MILLION)
  • 12. UK TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET SIZE, 2022-2030 ($ MILLION)
  • 13. FRANCE TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET SIZE, 2022-2030 ($ MILLION)
  • 14. GERMANY TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET SIZE, 2022-2030 ($ MILLION)
  • 15. ITALY TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET SIZE, 2022-2030 ($ MILLION)
  • 16. SPAIN TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET SIZE, 2022-2030 ($ MILLION)
  • 17. REST OF EUROPE TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET SIZE, 2022-2030 ($ MILLION)
  • 18. INDIA TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET SIZE, 2022-2030 ($ MILLION)
  • 19. CHINA TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET SIZE, 2022-2030 ($ MILLION)
  • 20. JAPAN TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET SIZE, 2022-2030 ($ MILLION)
  • 21. SOUTH KOREA TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET SIZE, 2022-2030 ($ MILLION)
  • 22. REST OF ASIA-PACIFIC TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET SIZE, 2022-2030 ($ MILLION)
  • 23. REST OF THE WORLD TRANSDERMAL DRUG DELIVERY SYSTEMS MARKET SIZE, 2022-2030 ($ MILLION)